fda warning letters compounded semaglutide tirzepatide 2025 US sends 25 to telehealth companies over claims on weight-loss drugs Fifth Circuit probes FDA ban

The Rs 10,000-crore opportunity According to the Elara Securities report, the GLP-1 drug category (used for diabetes and obesity) could grow to represent 4-5% of the entire Indian pharma market

You value a completely "clean" biological profile that ignores stress hormones like cortisol

Availability and access: Efficacy means nothing if the compound cant realistically be obtained

Once reconstituted or opened, most compounded tirzepatide vials are stable for 28 to 30 days when kept in the refrigerator

Retatrutide is administered exclusively by subcutaneous injection

Ask your provider or telehealth service directly which pharmacy is compounding your medication, and check that pharmacy's licensing status through your state pharmacy board's website